Skip to Content Facebook Feature Image

NBA Hall of Famer Dwyane Wade and NBA All-Star D'Angelo Russell Invest in Global Platform KICKS CREW

Business

NBA Hall of Famer Dwyane Wade and NBA All-Star D'Angelo Russell Invest in Global Platform KICKS CREW
Business

Business

NBA Hall of Famer Dwyane Wade and NBA All-Star D'Angelo Russell Invest in Global Platform KICKS CREW

2025-06-16 23:00 Last Updated At:23:15

Partnership to debut at Fanatics Fest with Way of Wade Experience and exclusive KICKS CREW x Way of Wade DLO 1 collaboration (Limited to 300 pairs worldwide) 

NEW YORK, June 16, 2025 /PRNewswire/ -- KICKS CREW, the leading global digital platform connecting millions of users to the products they love, proudly announces NBA Hall of Famer Dwyane Wade and NBA All-Star guard D'Angelo Russell as its newest investors and CREW Athletes, further cementing KICKS CREW's mission to create a new model where athletes don't just endorse brands—they build them.

A long-time advocate for athlete ownership and creative control, Dwyane Wade brings his deep-rooted legacy in footwear and global influence through his Way of Wade brand. For D'Angelo Russell, known for his creativity on and off the court, this investment signals his commitment to shaping what's next in sneaker culture and digital commerce.

"KICKS CREW is redefining what it means to empower athletes. This isn't just about selling sneakers—it's about ownership, control, and building something that lasts. With KICKS CREW, the Way of Wade brand can grow on a global scale while staying true to our vision. They give us the resources, platform, and freedom to create and distribute our products our way. That's the future, and I'm proud to be part of it," said Dwyane Wade.

"We're not just joining a marketplace—we're rewriting the rules," added D'Angelo Russell. "What KICKS CREW is building is bigger than products. It's about creativity, community, and giving athletes a platform to move culture in real time. I had to be a part of that."

KICKS CREW serves millions of customers in over 100 countries and has been instrumental in introducing international brands, like Way of Wade, to global markets. With a proven track record of successful Way of Wade launches and an established, growing customer base, KICKS CREW is uniquely positioned to scale the brand globally. This partnership will deepen that relationship, providing Way of Wade with full-spectrum support across product development, marketing, and international distribution, while maintaining creative and operational control.

"Dwyane Wade has always been ahead of the curve—from his legendary career to how he's championed athlete ownership and international sneaker culture through Way of Wade," said Ross Adrian Yip, co-founder of KICKS CREW. "With Dwyane and D'Angelo, we're not just launching signature products—we're building a future where athletes lead with direct ownership in their own platform. Their belief in what we're creating is a huge step forward as we integrate content, storytelling, and product into a unified global platform."

This new partnership will officially launch at Fanatics Fest NYC (June 20 - 22), where Dwyane Wade, D'Angelo Russell, and KICKS CREW will host an immersive booth celebrating the legacy of Way of Wade and offer exclusive first access to the KICKS CREW x Way of Wade DLO 1 'Royal Blue Skies' collaboration limited to 300 pairs worldwide. The space will feature interactive product storytelling, autographed memorabilia giveaways, and exclusive content designed to showcase the future of athlete-built brands.

ABOUT KICKS CREW

KICKS CREW is the world's most trusted digital platform for footwear, apparel, and collectibles, connecting brands and retailers with a global community of consumers. With authenticity at our core, every item is sourced directly from authorized partners and brands, ensuring transparency and trust at every step. Supported by sports icons Damian Lillard, Kyrie Irving, and Dwyane Wade, KICKS CREW redefines athlete empowerment. We empower athletes with unmatched ownership and control over their products, marketing, and distribution, allowing them to break free from traditional endorsement limitations. With comprehensive brand, product, marketing, and operational support powered by cutting-edge technology, KICKS CREW is creating the premier platform for athletes and brands to launch, scale, and control their businesses. 

ABOUT DWYANE WADE

Dwyane Wade is an entrepreneur with partnerships including Way of Wade, MISSION, Stance, BallerTV, Proudly, Aramis, Versace, TMRW Sports, Wade Cellars, Thorne, and Jeeter. Wade has stakes in the Utah Jazz, Chicago Sky, and Smith Entertainment Group. The WY Network is Wade's digital show and podcast network, which includes the hero show Time Out, where you can find unfiltered basketball, lifestyle, and cultural conversations. Founder of 59th & Prairie Entertainment, he is an executive producer of Emmy and Oscar-winning projects. He is the New York Times bestselling author of A Father First, co-authored the New York Times bestselling children's book Shady Baby, and released his photographic memoir DWYANE in 2021. His Wade Family Foundation provides relief to marginalized communities in need. As an NBA player for sixteen seasons and primarily with the Miami Heat, he was selected as an NBA All-Star 13 times, won three NBA championships, and was named the 2006 NBA Finals Most Valuable Player. He is an Olympic Gold medalist, was named to the NBA's 75th Anniversary team as one of the 75 greatest players in NBA history, and was inducted into the 2023 Naismith Memorial Basketball Hall of Fame. In 2024, his legacy was cemented in Miami Heat history when he became the team's first player to have a statue erected outside the Kaseya Center.

ABOUT D'ANGELO RUSSELL

D'Angelo Russell is a professional basketball player in the National Basketball Association (NBA). Drafted second overall in the 2015 NBA Draft, Russell quickly rose to prominence with his high basketball IQ and playmaking. In 2019, he made his first NBA All-Star appearance and became the first signature athlete for Way of Wade, launching the next chapter of his career by merging his passion for performance and personal storytelling through footwear and design.

ABOUT WAY OF WADE

Launched in 2012 in partnership with Li-Ning, the Way of Wade line is one of the best-selling performance basketball lines worldwide. Each iteration of the Way of Wade series is a testament to Wade's influence on basketball and fashion, blending performance with design to create shoes that resonate with fans worldwide. The Way of Wade brand continues to evolve, reflecting Wade's ongoing contributions to sports, fashion, and philanthropy.

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

NBA Hall of Famer Dwyane Wade and NBA All-Star D'Angelo Russell Invest in Global Platform KICKS CREW

NBA Hall of Famer Dwyane Wade and NBA All-Star D'Angelo Russell Invest in Global Platform KICKS CREW

T. Rowe Price Investment Management, Inc. and Braidwell LP participate as new investors

Stephen Williams, MD, Ph.D. joins as Chief Scientific Officer

Rebecca Chambers and Frank Witney, Ph.D. appointed to Board of Directors

FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision proteomics dedicated to advancing the early detection of disease, announced the close of an oversubscribed convertible notes financing, bringing in more than $50 million of new capital. Accounts advised by T. Rowe Price Investment Management, Inc. and Braidwell LP joined the financing as new investors. Existing investors, including Illumina Ventures and Sands Capital, also participated. The financing will support the continued commercial advancement of Alamar's precision proteomics platform.

"We deeply appreciate the continued support from our existing investors and are excited to welcome our new partners," said Dr. Yuling Luo, founder, chairman, and chief executive officer of Alamar. "Their confidence in our vision and strategy underscores the transformative potential of our work. This investment will enable us to accelerate innovation and continue to expand the reach of our platform, unlocking the full value of precision medicine and early disease detection."

Leadership and Board Expansion
Alamar also announced key additions to its executive leadership team and board of directors to support the company's continued growth and commitment to operational excellence.

 

 

To further strengthen its scientific leadership, Alamar welcomes Dr. Stephen Williams as Chief Scientific Officer. Steve brings more than three decades of experience in precision medicine and biomarker innovation. He most recently served as Chief Medical Officer at Standard BioTools and SomaLogic, and previously spent 18 years at Pfizer in senior leadership roles. A recognized leader in the scientific community, he has served on the NIH National Advisory Council for Biomedical Imaging and Bioengineering, helped launch the Alzheimer's Disease Neuroimaging Initiative, and co-founded the FDA-FNIH-PhRMA Biomarker Consortium.

Alamar has also appointed Rebecca Chambers and Dr. Frank Witney as directors to its board. Rebecca, Chief Financial Officer at Veracyte, brings deep financial and healthcare leadership experience from her current role as well as previous positions at Outset Medical, Illumina, Myriad Genetics and Life Technologies. Frank, an operating partner at Ampersand Capital Partners, adds over three decades of life sciences leadership experience, including serving as President and CEO of Affymetrix and Dionex Corporation, and currently sits on the boards of Revvity, Cerus Corporation, Standard BioTools, and several private companies.

"I am thrilled to welcome Steve to our leadership team, and Rebecca and Frank to our board of directors," said Dr. Yuling Luo. "Their deep expertise and diverse perspectives will be invaluable as we accelerate our mission to unleash the power of our Precision Proteomics platform, to enable broad impacts across health and disease. This is an exciting moment for Alamar, and we look forward to the impact their leadership will have on driving innovation and growth."

About Alamar Biosciences, Inc. 
Alamar Biosciences is a privately held life sciences company dedicated to powering precision proteomics to enable the earliest detection of disease. Leveraging its proprietary NULISA™ technology and the ARGO™ HT System, Alamar's platform is designed to deliver ultra-high sensitivity and addresses key limitations of existing technologies to deliver precision proteomics. For more information, please visit alamarbio.com

 

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

Recommended Articles